Latency associated protein construct with aggrecanase sensitive cleavage site
作者： Yuti Chernajovsky , Gillian Adams
DOI:
关键词:
摘要: The present provides a fusion protein comprising latency associated peptide (LAP) and pharmaceutically active agent in which the LAP are connected by an amino acid sequence aggrecanase proteolytic cleavage site.
lens.org 参考文章(42)
Edwin C. Ethridge, Alveolar bone grafting process with controlled surface active ceramics ,(1985)
Ducheyne P, Bioceramics: material characteristics versus in vivo behavior. Journal of Biomedical Materials Research. ,vol. 21, pp. 219- 236 ,(1987)
Yannis Tsouderos, Pascale Deloffre, Michel Wierzbicki, Use of strontium salts and pharmaceutical compositions thereof for the treatment of arthrosis ,(1997)
Peter John Smith, Harbans Kaur Mangat, Cobalt glass compositions for coatings ,(1994)
Mark Robert Towler, Daniel Boyd, A synthetic graft having a glass network ,(2006)
Richard Michael Day, Bioactive material for use in stimulating vascularization (2004). ,(2004)
José Zimmer, Karine Seneschal, Susanne Kessler, Jörg Hinrich Fechner, Glass compositions as an antimicrobial additive for dental materials ,(2005)
Larry L. Hench, Rounan Li, Arthur E. Clark, Alkali-free bioactive sol-gel compositions ,(1990)
Hanna Stina Dreja, Yuti Chernajovsky, Gillian Adams, Latent fusion protein ,(2001)
Erich Wanek, Werner Zollner, Jan Helms, Oswald Gasser, Gotz Geyer, Bone replacement part made of glass ionomer cement ,(1992)